Samsung launches third rival to AbbVie's Humira drug in EU
October 17, 2018 at 03:43 AM EDT
South Korea's Samsung Bioepis and its partner Biogen have launched a third rival to AbbVie's blockbuster medicine Humira in Europe, ramping up competition for a slice of the world's top-selling prescription drug's sales.